|
User Fee Talks Near the Wire As FDA, Industry Butt Heads
Devicemakers and the FDA remain divided on the terms of Medical Device User Fee and Modernization Act (MDUFMA) reauthorization as the deadline approaches for resolving differences.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives